Ventilator-associated Pneumonia
📧 Sign up to get email alerts when something new happens for Ventilator-associated Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Therapy in Critically Ill Patients With Ventilator-associated Pneumonia [Phase 4]
Phase 4 clinical trial update on combining a respiratory multiplex PCR with algorithm-based therapy to improve early antibiotic optimization…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central Line Bloodstream Infection in Intensive Care Unit in Bangladesh [NA]
A clinical trial in Bangladesh led by Hiroshima University aims to reduce ventilator-associated pneumonia, central line-associated bloodstre…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Impact of Nurses' Behavior Change and Evidence-Based Practice Implementation on Quality Indicators in Intensive Care Units in Low- and Middle-Income Countries [NA]
A Cairo University-supported clinical trial examines whether nurses’ behavior changes and implementation of evidence-based practices can imp…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: National Surveillance and Prevention of Neonatal VAP
A University of Alberta-sponsored clinical trial aimed at national surveillance and prevention of neonatal ventilator-associated pneumonia, …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Macrophage Programing in Acute Lung Injury: MiniBAL [NA]
This is a clinical trial update for a study on macrophage programming in acute lung injury (MiniBAL). The trial is currently recruiting part…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Patients at Increased Risk for the Development of Ventilator-associated Pneumonia in the Intensive Care Unit
This completed clinical trial assessed the structural and microbiological characteristics of endotracheal tube biofilms in ICU patients at i…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates. [NA]
A completed clinical trial evaluating whether lactoferrin can prevent ventilator-associated pneumonia in neonates.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients [NA]
This clinical trial explores using dynamic airway resistance measurements and machine learning to guide sputum suction in ventilated patient…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: TRacheal Cuff PRessure Evaluation Study [NA]
Clinical trial status update for a not-yet-recruiting study evaluating tracheal cuff pressure in patients with ventilator-associated pneumon…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia [Phase 4]
This entry reports the completed Phase 4 trial evaluating clinical outcomes of inhaled amikacin in patients with ventilator-associated pneum…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: The Efficacy of Adjuvant Oral Care in Prevention of Ventilator Associated Pneumonia. [NA]
A completed clinical trial tested the effectiveness of adjuvant oral care in preventing ventilator-associated pneumonia, with results posted…
-
EMA approval · 2026-01-26EMA Authorised: Recarbrio (imipenem monohydrate;cilastatin sodium;relebactam monohydrate) — Merck Sharp & Dohme B.V.
EMA authorised Recarbrio (imipenem/cilastatin/relebactam) for use in Gram-negative bacterial infections, including hospital-acquired/ventila…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days [Phase 4]
A Phase 4 trial evaluating 4 versus 7 days of antibiotic therapy for early ventilator-associated pneumonia was terminated; results have been…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Multi-Center Diagnostic Stewardship Program to Improve Respiratory Culture Utilization in Critically Ill Children
A multicenter diagnostic stewardship trial to optimize respiratory culture use in critically ill children, currently enrolling by invitation…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex [Phase 3]
Phase 3 trial evaluating BV100 with low-dose Polymyxin B versus Colistin with high-dose ampicillin/sulbactam for hospital-acquired and venti…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia
A completed clinical trial update reports on the incidence of invasive aspergillosis in patients with ventilator-associated pneumonia.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation [NA]
This clinical trial evaluates using bacterial DNA detection to guide antibiotic choices in immunocompromised patients with hospital-acquired…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Diagnostic and Prognostic Value of Reticulated Platelet Fraction in Ventilator-Associated Pneumonia (REPLAY-VAP)
This clinical trial evaluates whether the reticulated platelet fraction can aid in diagnosing and predicting prognosis in ventilator-associa…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia [Phase 3]
A Phase 3 trial evaluating inhaled amikacin versus placebo for the prevention of ventilator-associated pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care Units [NA]
A completed clinical trial examining how tracheal cuff shape affects microaspiration in ICU patients on mechanical ventilation.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Impact of Oral Care on Ventilator Associated Pneumonia [NA]
Clinical trial assessing the impact of oral care on the incidence of ventilator-associated pneumonia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Effect of Implementing Evidence-based Practice and Nurse's Behavior Change on Quality of Care in Intensive Care Unit: Focus on Ventilator Associated Pneumonia in a Tertiary Hospital in Bangladesh [NA]
A clinical trial conducted by Hiroshima University in Bangladesh is evaluating whether implementing evidence-based practice and nurse behavi…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Effect of Two Oral Care Methods on Oral Flora and VAP in Mechanically Ventilated Patients [NA]
Clinical trial update on the effect of two oral care methods on oral flora and ventilator-associated pneumonia in mechanically ventilated pa…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit [NA]
The trial evaluates frequent standardized oral care in premature infants in the NICU to reduce microbial colonization and ventilator-associa…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024
This clinical trial update describes VAP incidence and adherence to the SRLF 2017 diagnostic criteria within an intensive care service for 2…